Georgii A
Haematol Blood Transfus. 1979;23:59-70. doi: 10.1007/978-3-642-67057-2_7.
Among the patients with chronic myeloproliferative diseases including clinical symptoms of chronic myelogenous leukemia--CML--two varying compartments with substantially differing histology of hemopoiesis were found: one with predominating granulopoiesis for which the usual term of chronic granylocytic leukemia--CGL--seems inadequate. The other with proliferation of granylopoiesis and megakaryopoiesis as a neoplasia with a mixed cellularity is observed to be different in its clinical course: there are often a leukemic or subleukemic cell counts, but mostly considerable increased platelets in the peripheral blood; there is a prolonged period of latency, a higher age group, an infrequent occurrence of blastic crisis and a regular outcome into myelofibrosis. This entity of chronic megakaryocytic granulocytic myelosis--CMGM--can be seen very frequently among myeloproliferative diseases. Among a total of 718 core biopsies from the bone marrow the CMGM-patients are up to 29% compared with 21% of the typical one-cell-line disease CGL. The Ph1-chromosome may be presented in the CMGM-entity likewise.
在患有慢性骨髓增殖性疾病且伴有慢性粒细胞白血病(CML)临床症状的患者中,发现了两个造血组织学显著不同的区域:一个以粒细胞生成占主导,对于此区域,慢性粒细胞白血病(CGL)这一常用术语似乎并不适用。另一个区域观察到粒细胞生成和巨核细胞生成增殖,作为一种具有混合细胞性的肿瘤,其临床病程有所不同:外周血中白细胞计数常为白血病或亚白血病水平,但血小板大多显著增多;潜伏期延长,发病年龄较大,很少发生原始细胞危象,且通常会发展为骨髓纤维化。这种慢性巨核细胞粒细胞性骨髓增生症(CMGM)在骨髓增殖性疾病中很常见。在总共718例骨髓芯针活检中,CMGM患者占比高达29%,而典型的单细胞系疾病CGL患者占比为21%。Ph1染色体同样可能出现在CMGM实体中。